The role of cytokines in activation of coagulation and fibrinolysis in Dengue Shock Syndrome

被引:84
作者
Suharti, C
van Gorp, ECM
Setiati, TE
Dolmans, WMV
Djokomoeljanto, RJ
Hack, CE
ten Cate, H
van der Meer, JWM
机构
[1] Univ Nijmegen, Med Ctr St Radboud, Dept Med, NL-6500 HB Nijmegen, Netherlands
[2] Diponegoro Univ, Dept Med, Fac Med, Semarang, Indonesia
[3] Diponegoro Univ, Dept Paediat, Fac Med, Semarang, Indonesia
[4] Dr Karladi Hosp, Semarang, Indonesia
[5] Slotervaart Hosp, Dept Med, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Acad Hosp, Dept Clin Chem, Amsterdam, Netherlands
[7] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Amsterdam, Netherlands
[8] Acad Med Ctr, Lab Expt Internal Med, Amsterdam, Netherlands
关键词
cytokines; coagulation; fibrinolysis; dengue shock syndrome;
D O I
10.1055/s-0037-1612941
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a prospective clinical study of 50 patients with Dengue Shock Syndrome (DSS), we investigated the association of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-1 receptor antagonist (IL-1Ra), and IL-6 with activation markers of coagulation (F1+2 and TATc) and fibrinolysis (t-PA, PAPc, and D-dimer). We found that TNF-alpha, IL-1beta and II-1Ra, but not IL-6, concentrations were elevated in the circulation during the early stage of infection and at discharge from hospital. TNF-alpha was significantly associated with D-dimer, an activation marker of fibrinolysis (p < 0.003), but not with activation markers of coagulation. IL-1beta was significantly associated with t-PA (p < 0.03). IL-1Ra was significantly associated with F1+2, TATc (p < 0.04 and p < 0.02, respectively), whereas IL-6 was significantly associated with both. activation markers of coagulation (F1+2 p < 0.03) and fibrinolysis (PAPc P = 0.002). Our data are in line with studies in bacterial sepsis, In severe dengue virus infection the same cytokines are involved in the onset and regulation of hemostasis.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 30 条
[1]  
Bhamarapravati Natth, 1997, P115
[2]   PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES [J].
BIEMOND, BJ ;
LEVI, M ;
TENCATE, H ;
VANDERPOLL, T ;
BULLER, HR ;
HACK, CE ;
TENCATE, JW .
CLINICAL SCIENCE, 1995, 88 (05) :587-594
[3]  
BOERMEESTER MA, 1995, ARCH SURG-CHICAGO, V130, P739
[4]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND INHIBITOR-2, ALPHA-2-ANTIPLASMIN, PLASMINOGEN, AND ENDOTOXIN LEVELS IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
JOO, GB ;
BRUSLETTO, B ;
KIERULF, P .
THROMBOSIS RESEARCH, 1990, 57 (02) :271-278
[5]  
DEBOER JP, 1993, CIRC SHOCK, V39, P59
[6]   ENDURANCE RUN INCREASES CIRCULATING IL-6 AND IL-1RA BUT DOWN-REGULATES EX-VIVO TNF-ALPHA AND IL-1-BETA PRODUCTION [J].
DRENTH, JPH ;
VANUUM, SHM ;
VANDEUREN, M ;
PESMAN, GJ ;
VANDERVENJONGEKRIJG, J ;
VANDERMEER, JWM .
JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (05) :1497-1503
[7]   Diagnostic value of dengue virus-specific IgA and IgM serum antibody detection [J].
Groen, J ;
Velzing, J ;
Copra, C ;
Balentien, E ;
Deubel, V ;
Vorndam, V ;
Osterhaus, ADME .
MICROBES AND INFECTION, 1999, 1 (13) :1085-1090
[8]   DENGUE VIRUSES AND MONONUCLEAR PHAGOCYTES .1. INFECTION ENHANCEMENT BY NON-NEUTRALIZING ANTIBODY [J].
HALSTEAD, SB ;
OROURKE, EJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (01) :201-217
[9]  
HINSHAW LB, 1990, CIRC SHOCK, V30, P279
[10]   AN ENZYME-LINKED IMMUNOSORBENT-ASSAY TO CHARACTERIZE DENGUE INFECTIONS WHERE DENGUE AND JAPANESE ENCEPHALITIS CO-CIRCULATE [J].
INNIS, BL ;
NISALAK, A ;
NIMMANNITYA, S ;
KUSALERDCHARIYA, S ;
CHONGSWASDI, V ;
SUNTAYAKORN, S ;
PUTTISRI, P ;
HOKE, CH .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 40 (04) :418-427